Aché Laboratórios EBITDA 2015-2021
In 2021, the Brazilian pharmaceutical company Aché Laboratórios Farmacêuticos S.A. generated earnings before interests, taxes, depreciation, and amortization (EBITDA) of approximately 1,051 million Brazilian reals. The company's EBITDA showed an overall uptrend during the analyzed period, with a slight decline between 2019 and 2020. This financial indicator was above one billion Brazilian reals in the last three years.